Table 1.

Demographic characteristics and medication use of study participants

Variable	Value (n=34)
Gender
Female	14 (41.2%)
Male	20 (58.8%)
Race
White or Caucasian	26 (76.5%)
Black or African-American	3 (8.8%)
Hispanic	5 (14.7%)
Age* (years)	64.5±7.6
Diabetes medication use†	33 (97.1%)
Lipid-lowering medication use‡	28 (82.4%)
Blood pressure medication use§	24 (70.6%)

*Values are mean ± SD.

†Medications included metformin, pioglitazone, glipizide, gliclazide, glyburide, glimepiride, sitagliptin, linagliptin, canagliflozin, saxagliptin, insulin, and insulin glargine.

‡Medications included simvastatin, atorvastatin, lovastatin, fenofibrate, omega-3-acid ethyl esters, and rosuvastatin.

§Medications included metoprolol, atenolol, nebivolol, carvedilol, lisinopril, valsartan, quinapril, ramipril, losartan, amlodipine, hydrochlorothiazide, and teralosin.